Increased sister chromatid exchange frequency in young women with breast cancer and in their first-degree relatives

被引:14
作者
Cefle, Kivanc [1 ]
Ucur, Ali
Guney, Nese
Ozturk, Sukru
Palanduz, Sukru
Tas, Faruk
Asoglu, Oktar
Bayrak, Aysegul
Muslumanoglu, Mahmut
Aydiner, Adnan
机构
[1] Univ Istanbul, Istanbul Fac Med, Dept Internal Med, Div Med Genet, TR-34093 Istanbul, Turkey
[2] Univ Istanbul, Istanbul Fac Med, Dept Internal Med, Div Med Oncol, TR-34093 Istanbul, Turkey
[3] Univ Istanbul, Istanbul Fac Med, Dept Gen Surg, TR-34093 Istanbul, Turkey
关键词
D O I
10.1016/j.cancergencyto.2006.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The well-known increased risk of breast cancer (BC) in first-degree relatives of patients with BC has been related to shared genetic factors including defective DNA repair, with loss of genomic integrity. On the other hand, it can be hypothesized that early-onset breast cancer is also associated with overburden of heritable factors leading to increased DNA injury. In this respect, we analyzed sister chromatid exchange frequency (SCE) in 20 women with breast cancer (all <= 40 years old), in their first-degree female relatives, and in 20 age-matched healthy females without a personal or family history of cancer. SCE was significantly increased (P < 0.05) in patients (7.17 +/- 1.81 per metaphase) and in their first-degree relatives (6.44 +/- 0.98), compared with controls (5.85 +/- 0.72). There was no difference in SCE frequency between patients and their first-degree relatives. We suggest that the increased SCE in patients reflects a genomic instability that may be operative in carcinogenesis. Further, genomic instability is shared also by first-degree relatives, although none of them had a history of breast cancer at the time of the study. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:65 / 67
页数:3
相关论文
共 27 条
[1]  
Barch MJ, 1991, ACT CYTOGENETICS LAB, P24
[2]   Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58 209 women with breast cancer and 101 986 women without the disease [J].
Beral, V ;
Bull, D ;
Doll, R ;
Peto, R ;
Reeves, G .
LANCET, 2001, 358 (9291) :1389-1399
[3]   SCE ANALYSIS IN HUMAN-LYMPHOCYTES OF A SPANISH CONTROL POPULATION [J].
CARBONELL, E ;
PERIS, F ;
XAMENA, N ;
CREUS, A ;
MARCOS, R .
MUTATION RESEARCH-ENVIRONMENTAL MUTAGENESIS AND RELATED SUBJECTS, 1995, 335 (01) :35-46
[4]   Significance of lymphocytic sister chromatid exchange frequencies in ovarian cancer patients [J].
Dhar, PK ;
Devi, S ;
Rao, TR ;
Kumari, U ;
Joseph, A ;
Kumar, MR ;
Nayak, S ;
Shreemati, Y ;
Bhat, SM ;
Bhat, KR .
CANCER GENETICS AND CYTOGENETICS, 1996, 89 (02) :105-108
[5]   Chromosome aberrations and sister chromatid exchange studies in patients with prostate cancer: Possible evidence of chromosome instability [J].
Dhillon, VS ;
Dhillon, IK .
CANCER GENETICS AND CYTOGENETICS, 1998, 100 (02) :143-147
[6]   SISTER-CHROMATID EXCHANGE (SCE) STUDIES IN BREAST-CANCER PATIENTS - A FOLLOW-UP-STUDY [J].
DHILLON, VS ;
BHASKER, R ;
KLER, RS ;
HUSAIN, SA .
CANCER GENETICS AND CYTOGENETICS, 1995, 80 (02) :115-117
[7]   Familial risks of breast cancer [J].
Easton, DF .
BREAST CANCER RESEARCH, 2002, 4 (05) :179-181
[8]   Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].
Ford, D ;
Easton, DF ;
Stratton, M ;
Narod, S ;
Goldgar, D ;
Devilee, P ;
Bishop, DT ;
Weber, B ;
Lenoir, G ;
Chang-Claude, J ;
Sobol, H ;
Teare, MD ;
Struewing, J ;
Arason, A ;
Scherneck, S ;
Peto, J ;
Rebbeck, TR ;
Tonin, P ;
Neuhausen, S ;
Barkardottir, R ;
Eyfjord, J ;
Lynch, H ;
Ponder, BAJ ;
Gayther, SA ;
Birch, JM ;
Lindblom, A ;
Stoppa-Lyonnet, D ;
Bignon, Y ;
Borg, A ;
Hamann, U ;
Haites, N ;
Scott, RJ ;
Maugard, CM ;
Vasen, H .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689
[9]   Bloom's syndrome .20. The first 100 cancers [J].
German, J .
CANCER GENETICS AND CYTOGENETICS, 1997, 93 (01) :100-106
[10]   Genetic epidemiology of cancer: From families to heritable genes [J].
Hemminki, K ;
Rawal, R ;
Chen, BW ;
Bermejo, JL .
INTERNATIONAL JOURNAL OF CANCER, 2004, 111 (06) :944-950